Skip to main content
logo
Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
106.49
+1.14 (1.08%)
At close: Aug 31, 2026, 4:00 PM EDT
106.50
+0.01 (0.01%)
After-hours: Aug 31, 2026, 7:58 PM EDT

Halozyme Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
12,0869,2847,6577,9148,5786,4107,8836,0837,2516,6645,1694,8825,0394,8845,1727,6945,4486,0625,4945,6595,788
Market Cap Growth (YoY)
41.20%44.84%-2.86%30.11%18.30%-3.81%52.51%24.59%43.89%36.44%-0.06%-36.54%-7.50%-19.43%-5.88%35.96%-5.87%-6.20%-8.67%-1.84%60.97%
Enterprise Value
14,03411,1429,6918,7519,5687,1998,8236,9518,2557,7336,3645,9296,2216,1376,3508,9406,4926,1565,6335,7225,911
Last Close Price
106.4978.2764.6367.3073.3452.0263.8147.8157.2452.3640.6836.9638.2036.0738.1956.9039.5444.0039.8840.2140.68

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
31.4922.4521.95-14.4111.5016.2413.7018.4819.7616.2117.3419.8520.9028.4738.0625.8016.5612.6314.0514.15
Forward PE
10.868.858.068.8510.318.6412.6210.3812.7612.2811.049.7711.2011.8214.8221.9216.1619.2218.2417.8917.61
PS Ratio
7.265.585.085.676.905.447.275.997.657.635.995.896.466.317.3411.669.3812.4411.6512.7612.50
PB Ratio
84.6064.6834.86162.1317.0219.2616.3516.7216.0223.0329.0758.2620.2232.3478.5445.3156.1720.6821.1128.7320.55
P/TBV Ratio
------------------21.1128.7320.55
P/FCF Ratio
14.9911.5211.4712.2814.2411.8615.9012.9918.4616.3212.2013.0814.2516.6819.6232.7022.9320.8919.1318.9921.85
P/OCF Ratio
14.7611.3411.3012.1514.0411.7015.6512.7018.0015.8711.9912.5713.6715.9718.5232.0422.6820.7419.0218.9021.61
PEG Ratio
-0.550.550.550.550.550.550.550.560.530.900.900.900.900.900.910.410.410.390.460.40

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
8.446.706.436.277.706.118.146.858.718.867.377.157.977.939.0113.5411.1812.6311.9512.9112.77
EV/EBITDA Ratio
13.3610.6110.179.7511.779.4913.1111.0914.9316.0813.8814.2215.6015.3219.0826.6022.3324.1518.6420.6319.81
EV/EBIT Ratio
14.8611.8011.2810.7212.9810.5514.7712.6117.3119.1116.6717.4318.5418.7123.7330.8926.0225.4518.7220.7419.90
EV/FCF Ratio
17.4113.8214.5213.5815.8813.3117.8014.8421.0218.9415.0315.8817.5920.9624.0937.9927.3321.2219.6119.2022.32

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
15.1815.189.9144.603.054.623.194.143.395.308.6218.276.1410.1323.219.0715.594.283.384.473.12
Debt / EBITDA Ratio
2.051.692.491.931.611.722.361.922.082.783.293.123.423.315.103.743.356.732.873.832.88
Debt / FCF Ratio
2.702.703.263.382.562.853.103.223.913.763.624.104.335.225.806.556.364.323.062.953.32
Net Debt / Equity Ratio
13.5713.578.4641.681.662.981.642.501.923.476.0114.264.207.8219.036.9412.853.560.360.700.22
Net Debt / EBITDA Ratio
1.851.851.952.271.031.311.171.451.572.092.332.872.632.953.763.514.294.100.310.500.21
Net Debt / FCF Ratio
2.422.422.783.161.391.831.591.942.212.462.523.202.964.044.755.015.253.600.330.470.24
Asset Turnover
0.730.580.760.660.610.500.570.570.490.440.510.470.500.370.390.460.410.410.360.42
Inventory Turnover
2.482.922.532.441.581.481.651.831.871.481.282.302.212.332.052.542.552.722.192.311.89
Quick Ratio
1.991.992.143.301.256.447.006.508.755.585.015.076.085.115.124.544.562.008.067.108.20
Current Ratio
2.712.712.764.661.598.368.397.8010.367.416.646.647.636.586.695.655.972.728.857.918.99
Return on Equity (ROE)
506.44%447.16%-204.93%167.55%162.12%111.66%134.24%147.69%159.66%234.92%205.14%163.59%275.74%134.49%173.03%126.38%32.79%105.17%111.60%431.64%
Return on Assets (ROA)
27.40%17.75%26.80%25.49%23.81%16.61%20.98%19.96%15.38%13.36%13.93%12.26%13.46%7.60%13.01%11.42%5.79%16.69%12.34%17.09%
Return on Invested Capital (ROIC)
11.14%7.38%14.86%13.10%12.58%9.13%10.40%10.36%7.31%6.05%6.62%5.56%5.72%3.06%5.84%5.20%3.04%17.73%16.62%25.71%
Return on Capital Employed (ROCE)
42.30%42.30%37.20%34.80%53.30%35.60%29.20%28.70%23.70%22.00%22.30%21.00%18.90%19.40%16.60%16.90%14.20%15.30%28.60%27.90%27.70%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
3.42%4.46%4.56%4.00%6.94%8.69%6.16%7.30%5.41%5.06%6.17%5.77%5.04%4.78%3.51%2.63%3.88%6.04%7.92%7.12%7.07%
FCF Yield
6.67%8.68%8.72%8.14%7.02%8.43%6.29%7.70%5.42%6.13%8.20%7.65%7.02%5.99%5.10%3.06%4.36%4.79%5.23%5.27%4.58%
Buyback Yield / Dilution
4.21%2.37%2.98%8.77%6.00%3.92%1.74%1.57%2.94%3.24%6.54%5.46%3.81%6.10%2.39%3.92%4.98%3.66%4.89%0.60%-3.24%
SEC Filings: 10-K · 10-Q